Biophytis (BPTSY)

Currency in USD
1.8050
0.0000(0.00%)
Closed·
BPTSY Scorecard
Full Analysis
Operates with a significant debt burden
BPTSY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.80501.8050
52 wk Range
1.33007.4800
Key Statistics
Prev. Close
1.805
Open
1.805
Day's Range
1.805-1.805
52 wk Range
1.33-7.48
Volume
-
Average Volume (3m)
329
1-Year Change
-71.3%
Book Value / Share
-1.37
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BPTSY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Biophytis News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Biophytis Company Profile

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics targets and activates key biological resilience pathways that can protect against and counteract the effects of the multiple biological and environmental stresses, including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company’s lead drug candidate is BIO101, an orally administered small molecule in development to treat neuromuscular diseases, including sarcopenia, Duchenne muscular dystrophy (DMD), and obesity, as well as treatment of severe respiratory failure in patients suffering from COVID-19. It also develops BIO201, an orally administered small molecule for the treatment of retinopathies, including dry age-related macular degeneration, and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its BIO101 for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.

Compare BPTSY to Peers and Sector

Metrics to compare
BPTSY
Peers
Sector
Relationship
P/E Ratio
−0.3x−2.3x−0.5x
PEG Ratio
0.000.020.00
Price/Book
−0.4x0.9x2.6x
Price / LTM Sales
-8.1x3.2x
Upside (Analyst Target)
-155.4%41.9%
Fair Value Upside
Unlock−1.7%4.3%Unlock

Earnings

Latest Release
Jul 11, 2025
EPS / Forecast
-0.66 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BPTSY Income Statement

FAQ

What Stock Exchange Does Biophytis Trade On?

Biophytis is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Biophytis?

The stock symbol for Biophytis is "BPTSY."

What Is the Biophytis Market Cap?

As of today, Biophytis market cap is 4.26M.

What Is Biophytis's Earnings Per Share (TTM)?

The Biophytis EPS (TTM) is -2.00.

From a Technical Analysis Perspective, Is BPTSY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Biophytis Stock Split?

Biophytis has split 2 times.

How Many Employees Does Biophytis Have?

Biophytis has 19 employees.

What is the current trading status of Biophytis (BPTSY)?

As of 24 Jul 2025, Biophytis (BPTSY) is trading at a price of 1.81, with a previous close of 1.81. The stock has fluctuated within a day range of 1.81 to 1.81, while its 52-week range spans from 1.33 to 7.48.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.